New Drug to Reduce Aging at Fasano Longevity Conference Dr. Douglas Vaughan will present original research on a New Drug that can Extend Human Healthspan at the November 7th Fasano Longevity Conference in Washington, DC. Dr. Vaughan is Director of the Potocsnak Longevity Institute at Northwestern University. He and his colleagues have developed a drug to reduce PAI-1 levels, a protein associated with blood clotting that causes a number of aging related disorders, as well as more severe COVID outcomes. Said Fasano Associates’ Mike Fasano, “Doug’s research offers the prospect of reduced morbidity and mortality in the senior population, and also offers a promising therapy to deal with the effects of long COVID. His will [...]

Jason Sutherland to Cover Structured Settlement Market at Fasano Longevity Conference Jason Sutherland is CEO of DRB Capital and also serves as Vice President of the National Association of Settlement Purchasers. He will share his insights on the current state of the structured settlement market. Said Mike Fasano, “Jason brings over 23 years of experience in specialty finance markets with him. He combines both detailed deal making talent with a policy level perspective and understands the structured settlement market as well as anyone. I am very much looking forward to his presentation.” The Fasano Conference is a time efficient, one-day event that covers the most current and relevant topics affecting the longevity markets, and has been [...]

Groundbreaking Spinal Cord Research at Fasano Longevity Conference Dr. Samuel Stupp will present original research on Spinal Cord Regeneration at the November 7th Fasano Longevity Conference in Washington, DC. Dr. Stupp is founding director of the Simpson Querrey Institute for BioNanotechnology and the Center for Regenerative Nanomedicine. His research team has developed a new injectable therapy that harnesses “dancing molecules” to reverse paralysis and repair tissue after severe spinal cord injuries. Said Fasano Associates’ Mike Fasano, “Sam’s research will be game changing. His therapy offers the chance to finally improve quality of life and life expectancy for spinal cord injury victims. His presentation will be particularly interesting to anyone with an interest in structured settlements [...]

200 Attend Fasano Longevity Conference Focused on Investments, Mortality Research, and Life Settlements

Fasano Longevity Conference to Cover Investments, Mortality Research and Life Settlements WASHINGTON, D.C.-(BUSINESS WIRE)-October 19, 2021: The Fasano Longevity Conference, which will be held on November 1st, will include a wide range of topics bearing on longevity markets, mortality and the economy. The Conference will start this year with an analysis of the Post-Covid Investment Outlook by keynote speaker, Tony Roth - Chief Investment Officer of Wilmington Trust.  Tony will be followed by two research presentations: The Risks and Benefits of Marijuana versus Opioids in Pain Relief by Dr. Steven Rigatti and The Impact of Sex on Gene Expression, Disease and Mortality by Dr. Barbara Stranger of Northwestern University. The morning sessions will end with a “State of the Life Settlement Market” presentation by [...]

Tony Roth, Chief Investment Officer of Wilmington Trust, to Keynote Fasano Longevity Conference Wilmington Trust’s CIO, Tony Roth, will speak to the Post-Covid Investment Outlook at the 18thAnnual Fasano Longevity Conference, to be held on Monday, November 1 in Washington, DC. Tony has been Chief Investment Officer for Wilmington Trust Investment Advisors, the investment advisory arm of M&T Bank Corporation, since 2014.  Before that, he served as CIO of Acquitaine Management. Said Mike Fasano, President, Fasano Associates, “There is a tremendous amount of uncertainty as to the ultimate impact of the Covid crisis on life settlement, fixed income and other institutional caliber investments. Tony Roth is a creative thinker whose insights on the post-Covid investment outlook [...]